962 related articles for article (PubMed ID: 7108223)
1. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
3. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
Horwitz MA; Silverstein SC
J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
[TBL] [Abstract][Full Text] [Related]
4. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
5. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
Holzer TJ; Edwards KM; Gewurz H; Mold C
J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
[TBL] [Abstract][Full Text] [Related]
6. Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytes.
Guckian JC; Christensen WD; Fine DP
J Immunol; 1978 May; 120(5):1580-6. PubMed ID: 659863
[TBL] [Abstract][Full Text] [Related]
7. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
[TBL] [Abstract][Full Text] [Related]
8. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
[TBL] [Abstract][Full Text] [Related]
9. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.
Blaser MJ; Smith PF; Repine JE; Joiner KA
J Clin Invest; 1988 May; 81(5):1434-44. PubMed ID: 3366901
[TBL] [Abstract][Full Text] [Related]
11. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG
Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958
[TBL] [Abstract][Full Text] [Related]
12. Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus.
Jung DJ; An JH; Kurokawa K; Jung YC; Kim MJ; Aoyagi Y; Matsushita M; Takahashi S; Lee HS; Takahashi K; Lee BL
J Immunol; 2012 Nov; 189(10):4951-9. PubMed ID: 23071283
[TBL] [Abstract][Full Text] [Related]
13. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
[TBL] [Abstract][Full Text] [Related]
14. Serum complement factor I decreases Staphylococcus aureus phagocytosis.
Cunnion KM; Buescher ES; Hair PS
J Lab Clin Med; 2005 Nov; 146(5):279-86. PubMed ID: 16242527
[TBL] [Abstract][Full Text] [Related]
15. Aggregation of human polymorphonuclear leucocytes during phagocytosis of bacteria.
Henricks PA; van der Tol ME; Verhoef J
Immunology; 1984 Aug; 52(4):671-8. PubMed ID: 6086503
[TBL] [Abstract][Full Text] [Related]
16. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
[TBL] [Abstract][Full Text] [Related]
17. The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Verhoef J
Immunology; 1979 Jul; 37(3):615-21. PubMed ID: 500119
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.
Verbrugh HA; van Dijk WC; van Erne ME; Peters R; Peterson PK; Verhoef J
Infect Immun; 1979 Dec; 26(3):808-14. PubMed ID: 393633
[TBL] [Abstract][Full Text] [Related]
19. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2.
Bredius RG; de Vries CE; Troelstra A; van Alphen L; Weening RS; van de Winkel JG; Out TA
J Immunol; 1993 Aug; 151(3):1463-72. PubMed ID: 8335940
[TBL] [Abstract][Full Text] [Related]
20. Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.
Cunnion KM; Zhang HM; Frank MM
Infect Immun; 2003 Feb; 71(2):656-62. PubMed ID: 12540542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
